{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:01:42Z","timestamp":1789542102931,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbagen.2014.12.009","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:50:11Z","timestamp":1418298611000},"page":"2111-2120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biosynthesis of cyclosporins and other natural peptidyl prolyl cis\/trans isomerase inhibitors"],"prefix":"10.1016","volume":"1850","author":[{"given":"Alfons","family":"Lawen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2014.12.009_bb0005","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1073\/pnas.1015773108","article-title":"Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate","volume":"108","author":"Andexer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0014-5793(98)00795-9","article-title":"Peptidyl-prolyl-cis\/trans-isomerase activity may be necessary for memory formation","volume":"431","author":"Bennett","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0015","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/JVI.69.4.2451-2461.1995","article-title":"Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein\u2013cyclophilin A interactions","volume":"69","author":"Billich","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0020","series-title":"Proc. Int. Conf., 3rd Meeting","first-page":"239","article-title":"Immunological properties of ciclosporin (Sandimmune\u00ae)","volume":"3","author":"Borel","year":"1985"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0025","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/infdis\/174.4.850","article-title":"The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25-quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus","volume":"174","author":"Borvak","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0030","doi-asserted-by":"crossref","first-page":"e1003496","DOI":"10.1371\/journal.pgen.1003496","article-title":"The genome of Tolypocladium inflatum: evolution, organization, and expression of the cyclosporine biosynthetic gene cluster","volume":"9","author":"Bushley","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0035","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/S0040-4039(01)88807-9","article-title":"The roles of alanine, aspartate and glutamate in lawsone biosynthesis in Impatiens balsamina","volume":"10","author":"Campbell","year":"1969","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0040","doi-asserted-by":"crossref","first-page":"34793","DOI":"10.1074\/jbc.M202191200","article-title":"Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A","volume":"277","author":"Clarke","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0045","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1093\/emboj\/16.14.4174","article-title":"Structural basis for the activation of phenylalanine in the non-ribosomal biosynthesis of gramicidin S","volume":"16","author":"Conti","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0050","author":"De-Eknamkul"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2012.11.011","article-title":"Alanine racemase from Tolypocladium inflatum: a key PLP-dependent enzyme in cyclosporin biosynthesis and a model of catalytic promiscuity","volume":"529","author":"di Salvo","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0060","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/S0021-9258(17)42019-9","article-title":"Mechanism of biosynthesis of cyclosporin A: evidence for synthesis via a single linear undecapeptide precursor","volume":"269","author":"Dittmann","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0065","series-title":"The Discovery of Natural Products with Therapeutic Potential","first-page":"49","article-title":"Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals","author":"Dreyfuss","year":"1994"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0070","unstructured":"M.M. Dreyfuss, M.H. Schreier, H. Tscherter and R. Wenger (15.06.1988), Cyclosporin peptolides, their preparation by fermentation or chemical synthesis and their use as pharmaceuticals. Eur. Patent Appl. EP 0 296 123 A2 (1989); Chem. Abstr. 1989, 111, 152146a. URL: http:\/\/www.google.com.au\/patents\/EP0296123B1?cl=en."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/3-540-29717-0_15","article-title":"Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis\/trans isomerases","volume":"172","author":"Edlich","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0080","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1016\/j.bmcl.2003.09.042","article-title":"Synthesis of non-immunosuppressive cyclophilin-binding cyclosporin A derivatives as potential anti-HIV-1 drugs","volume":"15","author":"Evers","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7164\/antibiotics.52.474","article-title":"Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties","volume":"52","author":"Fehr","year":"1999","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0090","first-page":"1101","article-title":"Nachweis einer Enzymkatalyse f\u00fcr die cis\u2013trans-Isomerisierung der Peptidbindung in prolinhaltigen Peptiden","volume":"43","author":"Fischer","year":"1984","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/337476a0","article-title":"Cyclophilin and peptidyl-prolyl cis\u2013trans isomerase are probably identical proteins","volume":"337","author":"Fischer","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.22131","article-title":"The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus","volume":"47","author":"Flisiak","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22835","article-title":"The cyclophilin inhibitor Debio 025 combined with PEG IFN\u03b12a significantly reduces viral load in treatment-na\u00efve hepatitis C patients","volume":"49","author":"Flisiak","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1517\/13543784.2012.658641","article-title":"Update on alisporivir in treatment of viral hepatitis C","volume":"21","author":"Flisiak","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07162","article-title":"Dynamic thiolation\u2013thioesterase structure of a non-ribosomal peptide synthetase","volume":"454","author":"Frueh","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virol.2009.10.043","article-title":"Multiple cyclophilins involved in different cellular pathways mediate HCV replication","volume":"397","author":"Gaither","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2009.05.002","article-title":"Cyclophilin inhibitors","volume":"13","author":"Gallay","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0130","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1021\/ja0587603","article-title":"Biosynthesis of pipecolic acid by RapL, a lysine cyclodeaminase encoded in the rapamycin gene cluster","volume":"128","author":"Gatto","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0135","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2006.03.059","article-title":"Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporine A, and NIM811","volume":"343","author":"Goto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0140","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1039\/b804602f","article-title":"Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs","volume":"26","author":"Graziani","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0145","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/anie.200453764","article-title":"Isolation and characterization of pre-rapamycin, the first macrocyclic intermediate in the biosynthesis of the immunosuppressant rapamycin by S. hygroscopicus","volume":"43","author":"Gregory","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0150","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/AAC.01627-10","article-title":"Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family","volume":"55","author":"Gregory","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0155","unstructured":"M.A. Gregory, S.J. Moss, Wilkinson, B., Novel compound and methods for its production. US Patent Appl. US 2012\/025181, 2012. URL: http:\/\/www.google.com\/patents\/US20120251581."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1042\/BST0380841","article-title":"A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection","volume":"38","author":"Halestrap","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0165","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporin A","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/341758a0","article-title":"A receptor for the immunosuppressant FK506 is a cis\u2013trans peptidyl-prolyl isomerase","volume":"341","author":"Harding","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-3083.2006.01702.x","article-title":"Immunosuppressive activity of the immunophilin-binding drug sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes","volume":"63","author":"H\u00e4rtel","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0180","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1021\/bi973162p","article-title":"Selective inactivation of parvulin-like peptidyl-prolyl cis\/trans isomerases by juglone","volume":"37","author":"Hennig","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7164\/antibiotics.45.133","article-title":"The preparation of [2-deutero-3-fluoro-D-Ala8]cyclosporin A by directed biosynthesis","volume":"45","author":"Hensens","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0190","unstructured":"M. Hijikata, K. Shimotohno, Watashi, K., Use of modified cyclosporins for the treatment of HCV disorders. U. S. Patent Appl. US 7,968,518 B2, 2011. URL: http:\/\/www.google.com\/patents\/US7968518."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0195","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/v4112558","article-title":"Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection","volume":"4","author":"Hopkins","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0200","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.00660-09","article-title":"SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro","volume":"54","author":"Hopkins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2012.02.024","article-title":"The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection","volume":"57","author":"Hopkins","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002030100324","article-title":"Structure and localization of cyclosporin synthetase, the key enzyme of cyclosporin biosynthesis in Tolypocladium inflatum","volume":"176","author":"Hoppert","year":"2001","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0215","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/S0040-4039(00)01267-3","article-title":"Synthetic routes to NEtXaa4-cyclosporin A derivatives as potential anti-HIV I drugs","volume":"41","author":"Hubler","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0220","series-title":"Biotechnology","first-page":"535","article-title":"Cyclosporins: recent developments in biosynthesis, pharmacology and biology, and clinical applications","volume":"Vol.7","author":"Kallen","year":"1997"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0225","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0168-8278(09)60624-3","article-title":"Saftey, and tolerability of NIM811, a novel cyclophilin inhibitor for HCV, following single and multiple ascending doses in healthy volunteers and HCV-infected patients","volume":"50","author":"Ke","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00705-013-1803-7","article-title":"Current and future therapies for hepatitis C virus infection: from viral proteins to host targets","volume":"159","author":"Imran","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0235","first-page":"522","article-title":"The structure of VibH represents nonribosomal peptide synthetase condensation, cyclization and epimerization domains","volume":"9","author":"Keating","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0240","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hlca.19850680318","article-title":"Peptide conformations. Part 30. Assignment of the 1H-, 13C-, and 15N-NMR spectra of cyclosporin A in CDCl3 and C6D6 by a combination of homo- and heteronuclear two-dimensional techniques","volume":"68","author":"Kessler","year":"1985","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0245","first-page":"S219","article-title":"Cell-free biosynthesis of cyclosporin A and analogues","volume":"50","author":"Kleinkauf","year":"1991","journal-title":"Biomed. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0250","unstructured":"S.Y. Ko, H. Kobel, B. Risenwirth, D. Seebach, R.P. Traber, R. Wenger and P. Bollinger (1991), Cyclosporine. Eur. Patent Appl. EP 0 484 281 B1. URL: https:\/\/data.epo.org\/gpi\/EP0484281B1-Cyclosporins."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0255","unstructured":"H.P. Kocher, E. Schneider-Scherzer, K. Schoergendorfer and G. Weber (1994), Recombinant Alanine Racemase and GAPDH from Tolypocladium. Int. Patent Appl. WO 9425606 A2. URL: http:\/\/worldwide.espacenet.com\/publicationDetails\/originalDocument;jsessionid=4CEB4B6642A0CA6DEDD629F07E3A7974.espacenet_levelx_prod_3?FT=D&date=19941110&DB=&&CC=WO&NR=9425606A2&KC=A2&ND=1&locale=en_EP."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/expr.1996.0132","article-title":"Plasmodium vivax: in vitro antiparasitic effect of cyclosporines","volume":"84","author":"Kocken","year":"1996","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.1122928","article-title":"Conformational switches modulate protein interactions in peptide antibiotic synthetases","volume":"312","author":"Koglin","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0270","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1432-1033.1997.00526.x","article-title":"The pipecolate-incorporating enzyme for the biosynthesis of the immunosuppressant rapamycin\u2013nucleotide sequence analysis, disruption and heterologous expression of rapP from Streptomyces hygroscopicus","volume":"247","author":"K\u00f6nig","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0275","series-title":"The Mycota. A comprehensive treatise on fungi as experimental systems for basic and applied research. Volume X, Industrial Applications","first-page":"129","article-title":"Immunosuppressants","volume":"Vol.7","author":"K\u00fcrnsteiner","year":"2002"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6468(08)70303-5","article-title":"Biosynthesis and mechanism of action of cyclosporins","volume":"33","author":"Lawen","year":"1996","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0285","doi-asserted-by":"crossref","first-page":"20452","DOI":"10.1016\/S0021-9258(20)80748-0","article-title":"Substrate specificities of cyclosporin synthetase and peptolide SDZ 214-103 synthetase. Comparison of the substrate specificities of the related multifunctional polypeptides","volume":"268","author":"Lawen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0290","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1016\/S0021-9258(19)38600-4","article-title":"Cyclosporin synthetase. The most complex peptide synthesizing multienzyme polypeptide so far described","volume":"265","author":"Lawen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0295","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.7164\/antibiotics.42.1283","article-title":"Cell-free biosynthesis of new cyclosporins","volume":"42","author":"Lawen","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0300","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1016\/S0021-9258(18)98439-5","article-title":"In vitro biosynthesis of [Thr2, Leu5, D-Hiv8, Leu10]-cyclosporin, a cyclosporin-related peptolide with immunosuppressive activity by a multienzyme polypeptide","volume":"266","author":"Lawen","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0305","first-page":"S260","article-title":"In vitro biosynthesis of [Thr2, Leu5, D-Hiv8, Leu10]-cyclosporin, a cyclosporin-related immunosuppressive peptolide","volume":"50","author":"Lawen","year":"1991","journal-title":"Biomed. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0310","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0300-9084(92)90092-S","article-title":"Enzymatic biosynthesis of cyclosporin A and analogues","volume":"74","author":"Lawen","year":"1992","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj3000395","article-title":"In vitro biosynthesis of ring-extended cyclosporins","volume":"300","author":"Lawen","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0320","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/S0168-8278(09)61047-3","article-title":"Safety and antiviral efficacy of 14days of the cyclophilin inhibitor NIM811 in combination with pegylated interferon \u03b12a in relapsed genotype 1 HCV infected patients","volume":"50","author":"Lawitz","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0325","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.antiviral.2011.01.003","article-title":"Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14days of therapy","volume":"89","author":"Lawitz","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/znb-1968-0224","article-title":"Zur Biogenese von 5-Hydroxy-1,4-napthoquinone (Juglon) in Juglans regia L. [On the biogenesis of 5-hydroxy-1,4-napthoquinone (juglone) in Juglans regia L.]","volume":"23","author":"Leistner","year":"1968","journal-title":"Z. Naturforsch. B"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0335","series-title":"Antiviral Drugs From Basic Discovery Through Clinical Trials","first-page":"317","article-title":"Discovery of cyclophilin inhibitor NIM811 as a novel therapeutic agent for HCV","author":"Lin","year":"2011"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0340","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1021\/jm0109863","article-title":"Cyclosporins: structure\u2013activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter","volume":"45","author":"Loor","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0345","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/380544a0","article-title":"A human peptidyl-prolyl isomerase essential for regulation of mitosis","volume":"380","author":"Lu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0350","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1021\/cr960029e","article-title":"Modular peptide synthetases involved in nonribosomal peptide synthesis","volume":"97","author":"Marahiel","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0355","doi-asserted-by":"crossref","first-page":"12120","DOI":"10.1073\/pnas.182156699","article-title":"Crystal structure of DhbE, an archetype for aryl acid activating domains of modular nonribosomal peptide synthetases","volume":"99","author":"May","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cld.2012.09.008","article-title":"Cyclophilin inhibitors for hepatitis C therapy","volume":"17","author":"Membreno","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0365","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1099\/0022-1317-78-4-825","article-title":"The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells","volume":"78","author":"Mlynar","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0370","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/C1MD00227A","article-title":"Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection","volume":"3","author":"Moss","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0375","unstructured":"S.J. Moss, B. Wilkinson and M.A. Gregory (2012b), Macrocyclic compounds and methods for their production. Int. Patent Appl. WO 2012\/131377 A1. URL: http:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2012131377&recNum=183&docAn=GB2012050707&queryString=%28%28&."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0380","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0031-9422(00)86833-8","article-title":"1,4-Naphthoquinone, an intermediate in juglone (5-hydroxy-1,4-naphthoquinone) biosynthesis","volume":"15","author":"M\u00fcller","year":"1976","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0385","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1021\/bi00237a023","article-title":"Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation","volume":"30","author":"Nielsen","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0390","doi-asserted-by":"crossref","first-page":"26127","DOI":"10.1016\/S0021-9258(19)74290-2","article-title":"Biosynthesis of the unusual amino acid (4R)-4-[(E)-2-butenyl]-4-methyl-l-threonine of cyclosporine A. Identification of 3(R)-hydroxy-4(R)-methyl-6(E)-octenoic acid as a key intermediate by enzymatic in vitro synthesis and by in vivo labeling techniques","volume":"268","author":"Offenzeller","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0395","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1021\/bi960224n","article-title":"Biosynthesis of the unusual amino acid (4R)-4-[(E)-2-butenyl]-4-methyl-l-threonine of cyclosporine A: enzymatic analysis of the reaction sequence including identification of the methylation precursor in a polyketide pathway","volume":"35","author":"Offenzeller","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0400","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ja.2010.126","article-title":"Hutchinson's legacy: keeping on polyketide biosynthesis","volume":"64","author":"Olano","year":"2011","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0405","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hlca.19760590509","article-title":"Crystal and molecular structure of an Iodo derivative of the cyclic undecapeptide cyclosporin A","volume":"59","author":"Petcher","year":"1976","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0410","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1039\/C0MB00234H","article-title":"Cloning, sequencing and characterization of the biosynthetic gene cluster of sanglifehrin A, a potent cyclophilin inhibitor","volume":"7","author":"Qu","year":"2011","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0415","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1358\/dof.1995.020.06.300693","article-title":"SDZ NIM 811. A novel nonimmunosuppressive natural cyclosporin with anti-HIV activity","volume":"20","author":"Rosenwirth","year":"1995","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0425","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hlca.19760590412","article-title":"Cyclosporine A ein immunsuppressiv wirksamer Peptidmetabolit aus Trichoderma polysporum (LINK ex PERS.) Rifai","volume":"59","author":"R\u00fcegger","year":"1976","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0430","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.str.2007.05.008","article-title":"Structural and functional insights into a peptide bond-forming bidomain from a nonribosomal peptide synthetase","volume":"15","author":"Samel","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0435","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7164\/antibiotics.52.466","article-title":"Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity","volume":"52","author":"Sanglier","year":"1999","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0440","unstructured":"P. Scalfaro, J.-M. Dumont, G. Vuagniaux and R.-Y. Mauvernay (03. 10. 2005), Use of [D-MeAla]3-[EtVal]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MeAla]3-[EtVal]4-cyclosporin. Int. Patent Appl. WO 2006\/038088 A1. URL: http:\/\/patentscope.wipo.int\/search\/en\/WO2006038088."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0445","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0014-5793(92)80712-P","article-title":"Cyclosporin synthetase is a 1.4MDa multienzyme polypeptide. Re-evaluation of the molecular mass of various peptide synthetases","volume":"307","author":"Schmidt","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0450","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF01212947","article-title":"Reversal of multidrug resistance (MDR) by novel in vitro biosynthesized cyclosporin A analogues and the cyclopeptolide SDZ 214-103","volume":"121","author":"Schwabe","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0455","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1073\/pnas.92.17.7839","article-title":"The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin","volume":"92","author":"Schwecke","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0460","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/ja021327y","article-title":"Sanglifehrin\u2013cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data","volume":"125","author":"Sedrani","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0465","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1432-1033.1991.tb16167.x","article-title":"Selective 13C-labelling of cyclosporine A","volume":"199","author":"Senn","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0470","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1128\/JVI.78.23.12800-12808.2004","article-title":"Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity","volume":"78","author":"Sokolskaja","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0475","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1074\/jbc.270.11.6163","article-title":"Modular structure of peptide synthetases revealed by dissection of the multifunctional enzyme GrsA","volume":"270","author":"Stachelhaus","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6968.1995.tb07328.x","article-title":"Modular structure of genes encoding multifunctional peptide synthetases required for non-ribosomal peptide synthesis","volume":"125","author":"Stachelhaus","year":"1995","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0485","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.7604280","article-title":"Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains","volume":"269","author":"Stachelhaus","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0490","doi-asserted-by":"crossref","first-page":"22773","DOI":"10.1074\/jbc.273.35.22773","article-title":"Peptide bond formation in nonribosomal peptide biosynthesis. Catalytic role of the condensation domain","volume":"273","author":"Stachelhaus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0495","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1128\/JVI.69.2.814-824.1995","article-title":"Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication","volume":"69","author":"Steinkasserer","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0500","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.171.2.542","article-title":"Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells","volume":"171","author":"Steinschulte","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0505","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biotechadv.2011.03.004","article-title":"Cyclosporin A \u2014 a review on fermentative production, downstream processing and pharmacological applications","volume":"29","author":"Survase","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0510","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1023\/A:1008990919682","article-title":"From Norway to Novartis: Cyclosporin from Tolypocladium inflatum in an open access bioprospecting regime","volume":"9","author":"Svarstad","year":"2000","journal-title":"Biodivers. Conserv."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0515","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1021\/jm500223x","article-title":"From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds","volume":"57","author":"Sweeney","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0520","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/337473a0","article-title":"Peptidyl-prolyl cis\u2013trans isomerase is the cyclosporin A-binding protein cyclophilin","volume":"337","author":"Takahashi","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0525","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/(SICI)1097-0282(1996)40:5<585::AID-BIP16>3.0.CO;2-G","article-title":"Conformational polymorphism in peptidic and nonpeptidic drug molecules","volume":"40","author":"Taylor","year":"1996","journal-title":"Pept. Sci."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0530","series-title":"Biotechnology of Antibiotics","first-page":"279","article-title":"Biosynthesis of cyclosporins","author":"Traber","year":"1997"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0535","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hlca.19870700103","article-title":"Neue Cyclosprine aus Tolypocladium inflatum. Die Cyclosporine K\u2013Z","volume":"70","author":"Traber","year":"1987","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/095632029400500507","article-title":"[MeIle4]cyclosporin, a novel natural cyclosporin with anti-HIV activity: structure elucidation and biosynthesis","volume":"5","author":"Traber","year":"1994","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0545","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1387-2656(03)09002-1","article-title":"Nonribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors \u2014 cyclosporin synthetase as a complex example","volume":"9","author":"Velkov","year":"2003","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0550","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1074\/jbc.M209719200","article-title":"Mapping of S-adenosyl-l-methionine binding site in the N-methyltransferase domain(s) of the multienzyme polypeptide cyclosporin synthetase","volume":"278","author":"Velkov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0555","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1562\/0031-8655(2003)077<0129:PLOTNM>2.0.CO;2","article-title":"Photoaffinity labelling of the N-methyltransferase domains of cyclosporin synthetase","volume":"77","author":"Velkov","year":"2003","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0560","series-title":"Biosynthesis and Molecular Genetics of Fungal Secondary Metabolites","first-page":"65","article-title":"Cyclosporines: biosynthesis and beyond","author":"Velkov","year":"2014"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0565","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pep.2005.07.012","article-title":"An improved purification procedure for cyclosporin synthetase","volume":"45","author":"Velkov","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0570","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.chembiol.2011.01.017","article-title":"Characterization of the N-methyltransferase activitie(s) of the multifunctional polypeptide cyclosporin synthetase","volume":"18","author":"Velkov","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6468(08)70276-5","article-title":"Cyclosporines, fungal metabolites with immunosuppressive activities","volume":"25","author":"von Wartburg","year":"1988","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0580","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bip.20240","article-title":"Peptidyl-prolyl isomerase inhibitors","volume":"84","author":"Wang","year":"2006","journal-title":"Pept. Sci."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0585","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00313798","article-title":"The peptide synthetase catalyzing cyclosporine production in Tolypocladium niveum is encoded by a giant 45.8-kilobase open reading frame","volume":"26","author":"Weber","year":"1994","journal-title":"Curr. Genet."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0590","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0969-2126(00)00120-9","article-title":"Solution structure of PCP, a prototype for the peptidyl carrier domains of modular peptide synthetases","volume":"8","author":"Weber","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2014.12.009_bb0595","unstructured":"R.M. Wenger, M. Mutter, P. Garrouste, R. Lysex, O. Turpin, G. Vuagniaux, V. Nicolas, L.N. Zanolari and R. Crabb\u00e9 (2010), Cycloundecadepsipeptide compounds and use of said compounds as a medicament. Int. Patent Appl. WO 2010\/052559 A1. URL: http:\/\/www.google.as\/patents\/WO2010052559A1?cl=und."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0600","first-page":"1315","article-title":"Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin","volume":"7","author":"Wolvetang","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbagen.2014.12.009_bb0605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1119(00)00171-2","article-title":"The FK520 gene cluster of Streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units","volume":"251","author":"Wu","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.bbagen.2014.12.009_bb9000","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1016\/S0021-9258(18)99934-5","article-title":"Purification and characterization of eucaryotic alanine racemase acting as key enzyme in cyclosporin biosynthesis","volume":"269","author":"Hoffmann","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2014.12.009_bb9005","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.38.8.1763","article-title":"Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog","volume":"38","author":"Rosenwirth","year":"1994","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416514004097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416514004097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T06:12:56Z","timestamp":1650780776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416514004097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0304416514004097"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2014.12.009","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biosynthesis of cyclosporins and other natural peptidyl prolyl cis\/trans isomerase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2014.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}